• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsAkums Drugs and Pharmaceuticals
    Picture of Akums Drugs and Pharmaceuticals logo

    AKUMS — Akums Drugs and Pharmaceuticals Share News

    IN₹669.000.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    • Market Cap
      IN₹102.43bn
    • Enterprise Value
      IN₹87.37bn
    • Revenue
      IN₹43.59bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • AKUMS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    AKUMS Dividends
    • India's Akum Drugs rises on agreement with South Korean co

      19/11/2024 07:25
    • India's Akums Drugs rises on deal with Canada-based Triple Hair

      16/10/2024 07:19
    • Brief: Akums Drugs And Pharmaceuticals Executes License & Distribution Agreement With Triple Hair

      16/10/2024 06:37
    • Brief: Akums Drugs Launches Famotidine, Calcium Carbonate, Magnesium Hydroxide In India

      09/10/2024 14:31
    • Brief: Akums Drugs And Pharmaceuticals Unit Commences Its Second Production Facility At Haridwar

      22/08/2024 13:24
    Previous12Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.